Aberrant leukemia-associated immunophenotype as potential harbinger of lineage switch in <i>KMT2A</i>-rearranged leukemia: a case series.

Yost, Christine M; Gaikwad, Amos S; Parsons, D Williams; Rabin, Karen R; Gant, Vincent U; Fisher, Kevin E; Marcogliese, Andrea N; Schafer, Eric S

Aberrant leukemia-associated immunophenotype as potential harbinger of lineage switch in KMT2A-rearranged leukemia: a case series.

Yost, Christine M; Gaikwad, Amos S; Parsons, D Williams; Rabin, Karen R; Gant, Vincent U; Fisher, Kevin E; Marcogliese, Andrea N; Schafer, Eric S.

Afiliação

Yost CM; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Gaikwad AS; Texas Children's Cancer and Hematology Centers, Houston, TX, USA.
Parsons DW; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Rabin KR; Texas Children's Cancer and Hematology Centers, Houston, TX, USA.
Gant VU; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Fisher KE; Texas Children's Cancer and Hematology Centers, Houston, TX, USA.
Marcogliese AN; Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Schafer ES; Texas Children's Cancer and Hematology Centers, Houston, TX, USA.

Leuk Lymphoma ; 61(14): 3515-3518, 2020 12.

Article em En | MEDLINE | ID: mdl-32876512

Assuntos

Leucemia; Proteína de Leucina Linfoide-Mieloide; Rearranjo Gênico; Humanos; Leucemia/diagnóstico; Leucemia/genética; Proteína de Leucina Linfoide-Mieloide/genética

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia / Proteína de Leucina Linfoide-Mieloide Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Leuk Lymphoma Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google